ACM
GILD icon

Alta Capital Management’s Gilead Sciences GILD Stock Holding History

Alta Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-187,534
Closed -$13.4M – 88
2016
Q4 		$13.4M Sell
187,534
-8,914
-5% -$663K 0.96% 37
2016
Q3 		$15.5M Sell
196,448
-12,746
-6% -$1.04M 0.97% 37
2016
Q2 		$17.5M Buy
209,194
+5,905
+3% +$524K 1.08% 34
2016
Q1 		$18.7M Buy
203,289
+111,288
+121% +$10M 1.15% 33
2015
Q4 		$9.31M Buy
92,001
+13,734
+18% +$1.43M 0.75% 36
2015
Q3 		$7.68M Sell
78,267
-1,162
-1% -$129K 0.65% 36
2015
Q2 		$9.3M Buy
79,429
+8,632
+12% +$943K 0.76% 35
2015
Q1 		$6.95M Buy
70,797
+11,857
+20% +$1.2M 0.59% 37
2014
Q4 		$5.55M Buy
58,940
+5,736
+11% +$593K 0.46% 39
2014
Q3 		$5.66M Buy
53,204
+894
+2% +$87.5K 0.52% 36
2014
Q2 		$4.34M Buy
52,310
+10,066
+24% +$784K 0.4% 39
2014
Q1 		$2.99M Buy
+42,244
New +$3.31M 0.29% 46

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Alta Capital Management's GILD Position: Q1 2017 in Review

Alta Capital Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 187,534 shares — an estimated $13.4M sold.

Alta Capital Management first reported a position in GILD in Q1 2014 and held it in 12 quarters. The position peaked at $18.7M in Q1 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Alta Capital Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Alta Capital Management sold 187,534 Gilead Sciences shares in Q1 2017, an estimated $13.4M.
  • Alta Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 12 quarters.
  • Alta Capital Management's Gilead Sciences position peaked at $18.7M in Q1 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Alta Capital Management's 13F filing for Q1 2017, filed 19 Apr 2017.